Cargando…

Diversity in the Circulation of Influenza A(H3N2) Viruses in the Northern Hemisphere in the 2018–19 Season

While vaccination is considered the most effective means to prevent influenza infection, its seasonal effectiveness varies, depending on the circulating influenza strains. Here, we characterized the circulation of influenza strains in October-2018 and March-2019 around the world. For this, we used n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pando, Rakefet, Stern, Shahar, Nemet, Ital, Glatman-Freedman, Aharona, Sefty, Hanna, Zuckerman, Neta S., Drori, Yaron, Friedman, Nehemya, McCauley, John W., Keinan-Boker, Lital, Mendelson, Ella, Daniels, Rodney S., Mandelboim, Michal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069444/ https://www.ncbi.nlm.nih.gov/pubmed/33924296 http://dx.doi.org/10.3390/vaccines9040375

Ejemplares similares

Predominance of a Drifted Influenza A (H3N2) Clade and Its Association with Age-Specific Influenza Vaccine Effectiveness Variations, Influenza Season 2018–2019
por: Glatman-Freedman, Aharona, et al.
Publicado: (2020)

The impact of SARS-CoV-2 on respiratory syndromic and sentinel surveillance in Israel, 2020: a new perspective on established systems
por: Glatman-Freedman, Aharona, et al.
Publicado: (2022)

Influenza A Virus Inhibits RSV Infection via a Two-Wave Expression of IFIT Proteins
por: Drori, Yaron, et al.
Publicado: (2020)

A(H1N1)pdm09 influenza infection: vaccine inefficiency
por: Friedman, Nehemya, et al.
Publicado: (2017)

Genetic divergence of Influenza A(H3N2) amino acid substitutions mark the beginning of the 2016–2017 winter season in Israel
por: Glatman-Freedman, Aharona, et al.
Publicado: (2017)

Ineffectiveness of the 2014-2015 H3N2 influenza vaccine
por: Mandelboim, Michal, et al.
Publicado: (2015)

Effectiveness of influenza vaccine in preventing medically-attended influenza virus infection in primary care, Israel, influenza seasons 2014/15 and 2015/16
por: Yaron-Yakoby, Hamutal, et al.
Publicado: (2018)

Effectiveness of BNT162b2 Vaccine Booster against SARS-CoV-2 Infection and Breakthrough Complications, Israel
por: Glatman-Freedman, Aharona, et al.
Publicado: (2022)

Under-diagnosis of SARS-CoV-2 infections among children aged 0–15 years, a nationwide seroprevalence study, Israel, January 2020 to March 2021
por: Indenbaum, Victoria, et al.
Publicado: (2021)

Epidemiological and Virological Characterization of Influenza B Virus Infections
por: Sharabi, Sivan, et al.
Publicado: (2016)

Forty five percent of the Israeli population were infected with the influenza B Victoria virus during the winter season 2015–16
por: Sharabi, Sivan, et al.
Publicado: (2017)

Comprehensive Analyses of SARS-CoV-2 Transmission in a Public Health Virology Laboratory
por: Zuckerman, Neta S., et al.
Publicado: (2020)

Genomic variation and epidemiology of SARS-CoV-2 importation and early circulation in Israel
por: Zuckerman, Neta S., et al.
Publicado: (2021)

The BNT162b2 vaccine effectiveness against new COVID-19 cases and complications of breakthrough cases: A nation-wide retrospective longitudinal multiple cohort analysis using individualised data
por: Glatman-Freedman, Aharona, et al.
Publicado: (2021)

Effectiveness of BNT162b2 Vaccine in Adolescents during Outbreak of SARS-CoV-2 Delta Variant Infection, Israel, 2021
por: Glatman-Freedman, Aharona, et al.
Publicado: (2021)

Effectiveness of BNT162b2 Vaccine against Omicron Variant Infection among Children 5–11 Years of Age, Israel
por: Glatman-Freedman, Aharona, et al.
Publicado: (2023)

A method to identify respiratory virus infections in clinical samples using next-generation sequencing
por: Kustin, Talia, et al.
Publicado: (2019)

Neutralizing Response against Variants after SARS-CoV-2 Infection and One Dose of BNT162b2
por: Lustig, Yaniv, et al.
Publicado: (2021)

The Rise and Fall of a Local SARS-CoV-2 Variant with the Spike Protein Mutation L452R
por: Mor, Orna, et al.
Publicado: (2021)

Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel
por: Lustig, Yaniv, et al.
Publicado: (2021)

Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection
por: Nemet, Ital, et al.
Publicado: (2021)

Transcriptomic profiling and genomic mutational analysis of Human coronavirus (HCoV)-229E -infected human cells
por: Friedman, Nehemya, et al.
Publicado: (2021)

The Concordance between Mumps and Rubella Sero-Positivity among the Israeli Population in 2015
por: Bassal, Ravit, et al.
Publicado: (2022)

Estimated Infection and Vaccine Induced SARS-CoV-2 Seroprevalence in Israel among Adults, January 2020–July 2021
por: Bassal, Ravit, et al.
Publicado: (2022)

COVID-19 vaccination and BA.1 breakthrough infection induce neutralising antibodies which are less efficient against BA.4 and BA.5 Omicron variants, Israel, March to June 2022
por: Kliker, Limor, et al.
Publicado: (2022)

Altered NKp46 Recognition and Elimination of Influenza B Viruses
por: Duev-Cohen, Alexandra, et al.
Publicado: (2020)

“The mothers have eaten unripe grapes and the children's teeth are set on edge”: the potential inter-generational effects of the Holocaust on chronic morbidity in Holocaust survivors’ offspring
por: Keinan-Boker, Lital
Publicado: (2014)

Outbreak of Influenza and Other Respiratory Viruses in Hospitalized Patients Alongside the SARS-CoV-2 Pandemic
por: Fratty, Ilana S., et al.
Publicado: (2022)

A COVID-19 call center for healthcare providers: dealing with rapidly evolving health policy guidelines
por: Glatman-Freedman, Aharona, et al.
Publicado: (2020)

Cocirculation of A(H3N2) and B/Victoria increased morbidity in hospitalized patients in the 2019–2020 A(H1N1)pdm09 predominant influenza season in Israel
por: Jurkowicz, Menucha, et al.
Publicado: (2023)

Human Coronavirus Infections in Israel: Epidemiology, Clinical Symptoms and Summer Seasonality of HCoV-HKU1
por: Friedman, Nehemya, et al.
Publicado: (2018)

Comparison of the new fully automated extraction platform eMAG to the MagNA PURE 96 and the well-established easyMAG for detection of common human respiratory viruses
por: Hindiyeh, Musa, et al.
Publicado: (2019)

Trends of Thyroid Cancer in Israel: 1980–2012
por: Keinan-Boker, Lital, et al.
Publicado: (2016)

A Significant Decrease in the Incidence of Shigellosis in Israel during COVID-19 Pandemic
por: Bassal, Ravit, et al.
Publicado: (2021)

Preventable Cancer in Israel
por: Magid, Avi, et al.
Publicado: (2022)

Second Primary Cancers After Primary Breast Cancer Diagnosis in Israeli Women, 1992 to 2006
por: Silverman, Barbara G., et al.
Publicado: (2016)

A Unique SARS-CoV-2 Spike Protein P681H Variant Detected in Israel
por: Zuckerman, Neta S., et al.
Publicado: (2021)

The SARS-CoV-2 Lambda variant and its neutralisation efficiency following vaccination with Comirnaty, Israel, April to June 2021
por: Zuckerman, Neta, et al.
Publicado: (2021)

Metformin Treatment and Cancer Risk: Cox Regression Analysis, With Time-Dependent Covariates, of 320,000 Persons With Incident Diabetes Mellitus
por: Dankner, Rachel, et al.
Publicado: (2019)

A feasibility study to assess the validity of administrative data sources and self-reported information of breast cancer survivors
por: Hamood, Rola, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_kskaoboj4d1splo359fgcqstce